Pinchas Cohen

Title(s)Adjunct Professor, Pediatrics
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    The University of Southern California and Buck Institute Nathan Shock Center
    NIH P30AG068345Sep 15, 2020 - May 31, 2025
    Role: Co-Principal Investigator
    Metformin-Regulated Mitochondrial Peptides and their Effects on Aging
    NIH R01AG069698Sep 15, 2020 - May 31, 2025
    Role: Principal Investigator
    Ethnic-specific Effects of Mitochondrial DNA Variants and Environmental Factors on Cognitive Functioning and Dementia
    NIH R01AG068405Aug 1, 2020 - Apr 30, 2025
    Role: Principal Investigator
    Ethnic-Specific Mitochondrial DNA Variations that Contribute to Dementia
    NIH R56AG062693Aug 15, 2019 - Jul 31, 2020
    Role: Principal Investigator
    Humanin is an AD resilience factor through its interaction with APOE4
    NIH RF1AG061834Sep 30, 2018 - Mar 31, 2023
    Role: Principal Investigator
    Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
    NIH R01CA231219Sep 17, 2018 - Aug 31, 2023
    Role: Co-Principal Investigator
    Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration
    NIH P01AG055369Feb 15, 2018 - Jan 31, 2023
    Role: Co-Principal Investigator
    Plasma Mitochondrial Peptide Assays as Biomarkers of Environmental Toxin Exposure
    NIH R01ES020812Sep 19, 2011 - Jun 30, 2016
    Role: Principal Investigator
    Humanin and Type 2 Diabetes
    NIH R21DK089447Sep 1, 2011 - Aug 31, 2013
    Role: Co-Principal Investigator
    Novel Mitochondrially Encoded Peptides and Their Role in Health and Disease
    NIH R01GM090311Sep 30, 2009 - Mar 31, 2016
    Role: Principal Investigator
    A family of novel mitochondrially-encoded peptides and their role in aging
    NIH R01AG034430Jul 15, 2009 - Jun 30, 2014
    Role: Principal Investigator
    The Role of IGF2 in Fetal Growth Restriction
    NIH R01HD047013Jun 1, 2004 - Mar 31, 2010
    Role: Principal Investigator
    IGF-I: A Nutrition-Regulated Target in Prostate Cancer
    NIH R01CA100938Jun 13, 2003 - May 31, 2008
    Role: Principal Investigator
    Genomic and Non-Genomic Effects of IGFBP-3 on Apoptosis
    NIH R01AG020954Sep 30, 2001 - Aug 31, 2006
    Role: Principal Investigator
    NIH R01AI040203Apr 1, 1998 - Mar 31, 2004
    Role: Principal Investigator
    NIH R01DK047591Sep 30, 1993 - Aug 31, 2002
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels. Clin Endocrinol (Oxf). 2013 Mar; 78(3):405-14. Cohen P, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, Germak J, American Norditropin Study Group. PMID: 22924571.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    2. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. J Clin Endocrinol Metab. 2010 May; 95(5):2089-98. Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group. PMID: 20207829.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    3. Optimizing growth hormone dosing in children with idiopathic short stature. Horm Res. 2009 Jan; 71 Suppl 1:70-4. Keni J, Cohen P. PMID: 19153511.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008 Nov; 93(11):4210-7. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM, 2007 ISS Consensus Workshop participants. PMID: 18782877.
      View in: PubMed   Mentions: 196     Fields:    Translation:HumansPHPublic Health
    5. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab. 2007 Jul; 92(7):2480-6. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group. PMID: 17356043.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    6. Controversy in clinical endocrinology: problems with reclassification of insulin-like growth factor I production and action disorders. J Clin Endocrinol Metab. 2006 Nov; 91(11):4235-6. Cohen P. PMID: 16954153.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    7. Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology. 2006 May; 147(5):2109-11. Cohen P. PMID: 16617154.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    8. Overview of the IGF-I system. Horm Res. 2006; 65 Suppl 1:3-8. Cohen P. PMID: 16508327.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    9. Insulin-like growth factors and their binding proteins in children born small for gestational age: implication for growth hormone therapy. Horm Res. 2003; 60 Suppl 3:115-23. Ali O, Cohen P. PMID: 14671408.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    10. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab. 2002 Jan; 87(1):90-8. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG, American Norditropin Clinical Trials Group. PMID: 11788629.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    11. Clinical implications of the IGF-cancer connection. Growth Horm IGF Res. 2001 Dec; 11(6):336-8. Cohen P. PMID: 11914020.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res. 2000 Dec; 10(6):297-305. Cohen P, Clemmons DR, Rosenfeld RG. PMID: 11161960.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    13. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues. J Endocrinol. 2000 Feb; 164(2):215-23. Cohen P, Nunn SE, Peehl DM. PMID: 10657857.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    Pinchas's Networks
    Concepts (75)
    Derived automatically from this person's publications.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department